Product NDC: | 0008-0407 |
Proprietary Name: | ANTIVENIN (MICRURUS FULVIUS) |
Non Proprietary Name: | antivenin (micrurus fulvius) |
Active Ingredient(s): | 1 g/10mL & nbsp; antivenin (micrurus fulvius) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0008-0407 |
Labeler Name: | Wyeth Pharmaceuticals Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA101099 |
Marketing Category: | BLA |
Start Marketing Date: | 19670601 |
Package NDC: | 0008-0407-03 |
Package Description: | 1 mL in 1 VIAL (0008-0407-03) |
NDC Code | 0008-0407-03 |
Proprietary Name | ANTIVENIN (MICRURUS FULVIUS) |
Package Description | 1 mL in 1 VIAL (0008-0407-03) |
Product NDC | 0008-0407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | antivenin (micrurus fulvius) |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19670601 |
Marketing Category Name | BLA |
Labeler Name | Wyeth Pharmaceuticals Company |
Substance Name | NORTH AMERICAN CORAL SNAKE ANTIVENIN (MICRURUS FULVIUS) (EQUINE) |
Strength Number | 1 |
Strength Unit | g/10mL |
Pharmaceutical Classes |